Radient Technologies Inc
XTSX:RTI
Radient Technologies Inc
XTSX:RTI
Price:
0.005
CAD
Market Closed
Market Cap:
CA$2.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Radient Technologies Inc
XTSX:RTI
|
CA |
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
US |
|
Korean Air Lines Co Ltd
KRX:003490
|
KR |
|
N
|
Nkt A/S
CSE:NKT
|
DK |
|
W
|
WeShop Holdings Ltd
NASDAQ:WSHP
|
JE |
|
Aguia Resources Ltd
ASX:AGR
|
AU |
|
Fameglow Holdings Ltd
HKEX:8603
|
HK |
|
Electrolux Professional AB (publ)
OTC:ECTXF
|
SE |
|
N
|
Navigator Company SA
ELI:NVG
|
PT |
|
T
|
Thua Thien Hue Construction Joint Stock Corp
VN:HUB
|
VN |
|
I
|
Insight Digital Partners II
NASDAQ:DYOR
|
US |
|
Walker Crips Group PLC
LSE:WCW
|
UK |
|
Brookfield Infrastructure Corp
NYSE:BIPC
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RTI.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RTI
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
RTI Competitors Multiples
Radient Technologies Inc Competitors
Radient Technologies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Radient Technologies Inc
XTSX:RTI
|
2.7m CAD | 0.9 | -0.2 | -0.9 | -0.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
